Head & Neck

NRG – HN005 at https://clinicaltrials.gov/study/NCT05050942

A randomized Phase II/III trial of de-intensified radiation therapy for patients with early-stage, P16-positive, non-smoking associated oropharyngeal cancer (GEP-NET)

Cancer Type: Oropharynx, squamous cell, P16+

Principal Investigator: Dr. Debra Brandt

Please contact Clinical Trials Office for more details: 561-263-5791